Keating Investment Counselors Inc Bristol Myers Squibb CO Transaction History
Keating Investment Counselors Inc
- $229 Million
- Q4 2024
A detailed history of Keating Investment Counselors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keating Investment Counselors Inc holds 11,417 shares of BMY stock, worth $684,905. This represents 0.28% of its overall portfolio holdings.
Number of Shares
11,417
Previous 8,757
30.38%
Holding current value
$684,905
Previous $453,000
42.38%
% of portfolio
0.28%
Previous 0.19%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,762Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.52 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.76 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.71 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.62 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $128B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...